Emil T. Kuriakose

Emil T. Kuriakose

Corporate Officer/Principal at TERNS PHARMACEUTICALS, INC.

Net worth: 385 484 $ as of 2024-03-30

44 year
Health Technology
Consumer Services

Profile

Emil T.
Kuriakose
is currently the Chief Medical Officer-Oncology at Terns Pharmaceuticals, Inc. He previously worked as a Medical Director at Novartis Oncology, Inc. from 2013 to 2016 and as Vice President & Head-Clinical Development at Calithera Biosciences, Inc. from 2017 to 2021.
He received his undergraduate degree from New York University and his doctorate from Stony Brook University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-09 58,750 ( 0.09% ) 385 400 $ 2024-03-30
2023-04-29 3,354 ( 0.07% ) 84 $ 2024-03-30

Emil T. Kuriakose active positions

CompaniesPositionStart
TERNS PHARMACEUTICALS, INC. Corporate Officer/Principal 2023-04-30
All active positions of Emil T. Kuriakose

Former positions of Emil T. Kuriakose

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2015-12-31
CALITHERA BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer -
See the detail of Emil T. Kuriakose's experience

Training of Emil T. Kuriakose

New York University Undergraduate Degree
Stony Brook University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Emil T. Kuriakose's experience

Connections

31

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
CALITHERA BIOSCIENCES, INC.

Health Technology

TERNS PHARMACEUTICALS, INC.

Health Technology

Private companies1

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Emil T. Kuriakose